Pharmacokinetic (PK) model generated based on the single ascending dose (SAD) data and the first multiple ascending dose (MAD) cohort. Model confirms the predicted dosing regimen for phase 2, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback